Matinas BioPharma (NYSE:MTNB) Holdings, Inc. (NYSE American:MTNB), a pharmaceutical company with a market capitalization of $3.1 million and currently trading at $0.61 per share, announced on ...

Matinas BioPharma (NYSE:MTNB) Holdings, Inc. (NYSE American:MTNB), a pharmaceutical company with a market capitalization of $3.1 million and currently trading at $0.61 per share, announced on Monday ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

LONDON, GREATER LONDON, UNITED KINGDOM, May 9, 2025 /EINPresswire.com/ -- How Big Is the Cryptococcosis Market and How Fast Is It Growing? The global cryptococcosis market is experiencing robust ...

Matinas BioPharma (MTND) filed a prospectus for the offer and sale of 16.89M shares of common stock by the selling stockholders. This preliminary prospectus is not an offer to sell these securities.

Copyright © 2025 MarketWatch, Inc. All rights reserved.

At close: May 14 at 4:00:00 PM EDT ...

1 Day MTNB 7.68% DJIA 2.66% Russell 2K 2.71% Health Care/Life Sciences 0.24% ...

At close: 2 May at 15:59:59 GMT-4 ...